A groundbreaking study by an international team of scientists, led by researchers from Israel’s University of Haifa, has unveiled a potential new avenue for understanding Parkinson’s disease (PD). The research, published in npj Parkinson’s Disease, a Nature journal, highlights a significant link between the disease and abnormalities in the brain’s extracellular matrix, a network critical for cellular support and communication.
The challenge in PD research has been the inability to model the disease accurately for the majority of patients, as only about 15% have a genetic risk factor identified as GBA1, leaving 85% of cases unexplained. The study tackled this issue by converting skin cells from patients with and without the GBA1 mutation, as well as from healthy individuals, into stem cells and then into nerve cells, carrying the same genetic makeup as the donors.
Give the gift of hope
We practice what we preach:
accurate, fearless journalism. But we can't do it alone.
- On the ground in Gaza, Syria, Israel, Egypt, Pakistan, and more
- Our program trained more than 100 journalists
- Calling out fake news and reporting real facts
- On the ground in Gaza, Syria, Israel, Egypt, Pakistan, and more
- Our program trained more than 100 journalists
- Calling out fake news and reporting real facts
Join us.
Support The Media Line. Save democracy.
The researchers discovered consistent changes in the genes controlling the extracellular matrix across all PD patient cells, regardless of their genetic background. Notably, there was a reduced presence of mRNA and proteins essential for building the extracellular matrix and a specific aggregation of the collagen IV protein in PD patients, an anomaly not observed in healthy participants.
This discovery points to the extracellular matrix as a critical factor in Parkinson’s disease, opening new paths for research and potentially leading to breakthroughs in treatment strategies.